Mashup Score: 0 TCTMD Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol - A new method of distinguishing Lp(a) in blood samples has implications for LDL tests and patient care, researchers say. 123456 Joel Kahn MD, FACC Hope for Lipoprotein(a) patients if the HORIZON trial proves safe and effective Read the full article here See more from Joel Kahn Share this article × facebook twitter email https://mashupmd.com/expert-articles-post/pelacarsen-targets-lpa-with-little-impact-on-ldl-cholesterol/ Copy Link
WSJ Coffee and Your Heart: The Impact May Be Different Than You Think #AtrialFibrillation #Cardiology Dr. Deepak L. Bhatt
OUP Academic Value of screening for the risk of sudden cardiac death in young competitive athletes #athletes #cardiotwitter EHJ Editor-in-Chief
PubMed 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Mana... Sam Tsimikas, MD
Journal of the American S Turning Up the Ethical Gain: The Importance of Accurate Echocardiographic Assessme... IANCARDIOLOGY
www.sciencedirect.com Habitual daily intake of a sweet and fatty snack modulates reward processing in hu... Pradeep Natarajan
Zoom Welcome! You are invited to join a webinar: Frontiers in Cardiovascular Science Se... #Cardiac #PrecisionMedicine Joseph C Wu, MD, PhD
www.bidmc.org BIDMC Research Guides FDA Action on Common Medical Device #SAFEAAA Eric Secemsky MD MSc
HMP Global Learning Netwo Novel High-Density Mapping Techniques for Atypical Atrial Flutter Characterization EP Lab Digest
Hope for Lipoprotein(a) patients if the HORIZON trial proves safe and effective